NHS

News

A male HCP discusses treatment with an older male patient

Bayer's prostate cancer drug Nubeqa cleared for NHS use

Thousands of men living with incurable prostate cancer will be able to access an easier-to-tolerate treatment from Bayer, thanks to new NICE guidance.

News

ViiV's bimonthly HIV PrEP jab cleared for use by NHS

ViiV's injectable HIV PrEP Apretude will soon be an alternative for people in England and Wales who cannot use daily oral options.

News

Pharmacist shelving medicine in pharmacy

NHS could pay more for medicines under new plan

Changes to the threshold used by NICE to measure cost-effectiveness could be on the way as part of a plan that would raise NHS spending on medicines.

News

NICE finalises support for CSL's HAE therapy Andembry

CSL Behring's Andembry can be used to prevent recurrent attacks of HAE by the NHS, following finalised guidance from reimbursement authority NICE.

R&D

From pilots to patients: Why the UK must rethink NHS innovat...

At PharmaTech Integrates in Glasgow, speakers from government, academia, the NHS, and pharma sought to define the sector’s path forward.

News

UK says 'online NHS hospital' will launch in 2027

The UK says a new online NHS hospital service due to start in 2027 will deliver up to 8.5m extra NHS appointments in its first three years.

Bayer's prostate cancer drug Nubeqa cleared for NHS use

ViiV's bimonthly HIV PrEP jab cleared for use by NHS

NHS could pay more for medicines under new plan

NICE finalises support for CSL's HAE therapy Andembry

From pilots to patients: Why the UK must rethink NHS innovat...

UK says 'online NHS hospital' will launch in 2027

Lilly's 'triple G' retatrutide aces crucial obesity trial

Discover a new era of healthcare panel engagement: Grounded ...

NHS

Editor's Picks